Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary G Liversidge

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|January 13, 2011
Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technologyElaine Merisko-Liversidge, Gary G Liversidge
Toxicologic Pathology|March 14, 2008
Drug nanoparticles: formulating poorly water-soluble compoundsElaine M Merisko-Liversidge, Gary G Liversidge
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2003
Nanosizing: a formulation approach for poorly-water-soluble compoundsElaine Merisko-Liversidge, Gary G Liversidge, Eugene R Cooper
Pharmaceutical Research|October 23, 2004
Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulinElaine Merisko-Liversidge, Simon L McGurk, Gary G Liversidge
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2008
In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazolJun-ichi Jinno, Naoki Kamada, Masateru Miyake, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2006
Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogsJun-ichi Jinno, Naoki Kamada, Masateru Miyake, et al.
Journal of Pharmaceutical Sciences|January 4, 2012
A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogsKevin Quinn, Rampurna Prasad Gullapalli, Elaine Merisko-Liversidge, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|January 13, 2011
Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technologyElaine Merisko-Liversidge, Gary G Liversidge
Toxicologic Pathology|March 14, 2008
Drug nanoparticles: formulating poorly water-soluble compoundsElaine M Merisko-Liversidge, Gary G Liversidge
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2003
Nanosizing: a formulation approach for poorly-water-soluble compoundsElaine Merisko-Liversidge, Gary G Liversidge, Eugene R Cooper
Pharmaceutical Research|October 23, 2004
Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulinElaine Merisko-Liversidge, Simon L McGurk, Gary G Liversidge
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2008
In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazolJun-ichi Jinno, Naoki Kamada, Masateru Miyake, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2006
Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogsJun-ichi Jinno, Naoki Kamada, Masateru Miyake, et al.
Journal of Pharmaceutical Sciences|January 4, 2012
A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogsKevin Quinn, Rampurna Prasad Gullapalli, Elaine Merisko-Liversidge, et al.
Pageof 1